Showing results (421-430 of 666) with videos related to
Sort By:
Pageof 67
Nature Medicine|August 1, 1997
The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomasA De Luca, A Baldi, V Esposito, et al.Cancer Research|November 1, 1993
Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testingG L Shaw, A F Gazdar, R Phelps, et al.AJR. American Journal of Roentgenology|January 11, 1991
Detection of ACTH-producing bronchial carcinoid tumors: MR imaging vs CTJ L Doppman, H I Pass, L K Nieman, et al.The Journal of Biological Chemistry|February 24, 1995
Malarial circumsporozoite protein is a novel gene delivery vehicle to primary hepatocyte cultures and cultured cellsZ M Ding, R J Cristiano, J A Roth, et al.Pacing and Clinical Electrophysiology : PACE|July 1, 1995
Reproducibility of electrophysiological testing during antiarrhythmic therapy for ventricular arrhythmias unrelated to coronary artery diseaseK J Ferrick, M Maher, J A Roth, et al.The Journal of Thoracic and Cardiovascular Surgery|November 1, 1996
Gene therapy for lung cancer: enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transferD M Nguyen, F R Spitz, N Yen, et al.Cancer Gene Therapy|September 11, 2007
Enhancement of antitumor activity of cisplatin in human lung cancer cells by tumor suppressor FUS1W-G Deng, G Wu, K Ueda, et al.Urology|August 8, 2001
Partial ureteral obstruction dysregulates the renal renin-angiotensin system in the fetal sheep kidneyS Ayan, J A Roth, M R Freeman, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1986
Monoclonal antibody 45-2D9 conjugated to the A chain of ricin is specifically toxic to c-Ha-ras-transfected NIH 3T3 cells expressing gp74J A Roth, R S Ames, V Byers, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1986
Human oncogene-transfected tumor cells display differential susceptibility to lysis by lymphokine-activated killer cells (LAK) and natural killer cellsL A Lanza, D J Wilson, B Ikejiri, et al.Pageof 67